The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Zlamy, Manuela ^a   Kofler, Sabine ^a   Orth, Dorothea ^a   Würzner, Reinhard ^a   Heinz Erian, Peter ^a   Streng, Andrea ^b   Prelog, Martina ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Blood stream infection; Children; Gastroenteritis; Rotavirus; Universal mass vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOODSTREAM INFECTION; CHILD; FATALITY; FEMALE; FUNDING; HEALTH CARE COST; HOSPITAL INFECTION; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NONHUMAN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; ROTAVIRUS GASTROENTERITIS; ROTAVIRUS INFECTION; SCHOOL CHILD; VIRAL GASTROENTERITIS;

ADOLESCENT; AUSTRIA; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS VACCINATION; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84874397445     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-112     Document Type: Article

References (48)

1. Glass RI, Parashar UD, Bresee US, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368:323-332. 10.1016/S0140-6736(06)68815-6, 16860702.
2. Anonymus Rotavirus Surveillance worldwide 2001-2008. Morb Mortal Wkly Rep 2008, 57:1255-1257. Anonymus.
3. Forster J, Guarino A, Parez N, Moraga F, Román E, Mory O, Tozzi AE, de Aguileta AL, Wahn U, Graham C, Berner R, Ninan T, Barberousse C, Meyer N, Soriano-Gabarró M, and the Rotavirus Study Group Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009, 123:e393-e400. 10.1542/peds.2008-2088, 19254975, and the Rotavirus Study Group.
4. Giaquinto C, Van Damme P. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. Scand J Infect Dis 2010, 42:142-147. 10.3109/00365540903380495, 19916900.
5. Rendi-Wagner P, Kundi M, Mikolasek A, Mutz I, Zwiauer K, Wiedermann U, Vécsei A, Kollaritsch H. Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003. Wien Klin Wochenschr 2006, 118:280-285. 10.1007/s00508-006-0599-9, 16810486.
6. Williams CJ, Lobanov A, Pebody RG. Estimated mortality and hospital admission due to rotavirus infection in the WHO European region. Epidemiol Infect 2009, 137:607-616. 10.1017/S0950268808001714, 19134232.
7. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:136-141. 10.1016/S1473-3099(11)70253-5, 22030330.
8. Ogilvie I, Khoury H, Goetghebeur MM, El Khoury AC, Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infectious Dis 2012, 12:62.
9. Fruhwirth M, Berger K, Ehlken B, Moll-Schuler I, Brosl S, Mutz I. Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria. Pediatr Infect Dis J 2001, 20:184-188. 10.1097/00006454-200102000-00013, 11224839.
10. Frühwirth M, Brösl S, Ellemunter H, Moll-Schüler I, Rohwedder A, Mutz I. Distribution of rotavirus VP4 genotypes and VP7 serotypes among nonhospitalized and hospitalized patients with gastroenteritis and patients with nosocomially acquired gastroenteritis in Austria. J Clin Microbiol 2000, 38:1804-1806. 86593, 10790103.
11. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J 2010, 29:319-323.
12. Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011, 29:2791-2796. 10.1016/j.vaccine.2011.01.104, 21320539.
13. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008, 21:198-208. 10.1128/CMR.00029-07, 2223838, 18202442.
14. Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, Yazdan Y, Beutels P. The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine 2009, 27:6121-6128. 10.1016/j.vaccine.2009.08.030, 19715781.
15. Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009, 200:S16-S27. 10.1086/605026, 19817595.
16. Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ. Economic evaluations of rotavirus immunization for developing countries: a review of the literature. Expert Rev Vaccines 2011, 10:1037-1051. 10.1586/erv.11.65, 21806398.
17. Bilcke H, Beutels P. Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. Pharmaeconomics 2009, 27:281-297.
18. Yen C, Tate JE, Wenk JD, Harris JM, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011, 127:e9-e15. 10.1542/peds.2010-1393, 21172995.
19. Clark HF, Lawley D, Matthijnssens J, Dinubile MJ, Hodinka RL. Sustained decline in cases of rotavirus gastroenteritis presenting to the Children's Hospital of Philadelphia in the new rotavirus vaccine era. Pediatr Infect Dis J 2010, 29:699-702. 10.1097/INF.0b013e3181d73524, 20661099.
20. Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2009, 127:e264-e277.
21. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010, 201:1617-1624. 10.1086/652403, 20402596.
22. Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. J Infect Dis 2009, 200:S49-S56. 10.1086/605036, 19817614.
23. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 2001, 3:1145-1156. 10.1016/S1286-4579(01)01475-7, 11709295.
24. Carneiro NB, Diniz-Santos DR, Amorim C, Galeno C, Raposo J, Brandão L, Magalhães M, Cathalá R, Sardeiro S, Mello C, Silva LR. Septic shock complicating acute Rotavirus-associated diarrhea. Pediatr Infect Dis J 2006, 6:571-572.
25. Lowenthal A, Livni G, Amir J, Samra Z, Ashkenazi S. Secondary bacteremia after Rotavirus gastroenteritis in infancy. Pediatrics 2006, 117:224-226. 10.1542/peds.2005-0177, 16396884.
26. Cicchetti R, Iacobini M, Midulla F, Papoff P, Mancuso M, Moretti C. Pantoea glomerans sepsis after rotavirus gastroenteritis. Pediatr Infect Dis J 2006, 25:280-281.
27. Kashiwagi Y, Sato S, Nakamura M, Kuboshima S, Numabe H, Kawashima H, Takekuma K, Hoshika A, Matsumoto T. Klebsiella oxytoca septicemia complicating rotavirus-associated acute diarrhea. Pediatr Infect Dis J 2007, 26:191-192.
28. Chiappini E, Galli L, de Martino M. Viremia and clinical manifestations in children with rotavirus infection. J Infect Dis 2006, 193:1333.
29. Mel E, Nahum E, Lowenthal A, Ashkenazi S. Extended spectrum beta-lactamase-positive Escherichia coli bacteremia complicating rotavirus gastroenteritis. Pediatr Infect Dis J 2006, 25:962.
30. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990, 22:259-267. 10.3109/00365549009027046, 2371542.
31. Statistik Austria [http://www.statistik.at], access: 5th February, 2013, Statistik Austria.
32. Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011, 127:e254-e270.
33. Rotbart HA, Nelson WL, Glode MP, Triffon TC, Kogut SJ, Yolken RH, Hernandez JA, Levin MJ. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr 1988, 112:87-93. 10.1016/S0022-3476(88)80128-8, 3257265.
34. Capitanio MA, Greenberg SB. Pneumoatosis intestinalis in two infants with rotavirus gastroenteritis. Pediatr Radiol 1991, 21:361-362. 10.1007/BF02011488, 1891264.
35. Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis 2010, 202:S43-S48. 10.1086/653548, 20684716.
36. Rougemont A, Kaplon J, Pillet S, Mory O, Gagneur A, Minoui-Tran A, Meritet JF, Mollat C, Lorrot M, Foulongne V, Gillet Y, Nguyen-Bourgain C, Alain S, Agius G, Lazrek M, Colimon R, Fontana C, Gendrel D, Pothier P, French Rotavirus Network Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in France. Pediatr Infect Dis J 2011, 30:118-124. 10.1097/INF.0b013e3181ef034e, 20686439, French Rotavirus Network.
37. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011, 204:980-986. 10.1093/infdis/jir492, 21878425.
38. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33. 10.1056/NEJMoa052664, 16394299, Rotavirus Efficacy and Safety Trial (REST) Study Team.
39. Cortese MM, Parashar UD, Centers for Disease Control and Prevention (CDC) Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58:1-25. Centers for Disease Control and Prevention (CDC).
40. Vesikari T, Itzler R, Karyonen A, Korhonen T, Van Damme P, Behre U, Bona G, Gothefors L, Heaton PM, Dallas M, Goveia MG. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vaccine 2009, 28:345-351. 10.1016/j.vaccine.2009.10.041, 19879226.
41. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008, 8:642-649. 10.1016/S1473-3099(08)70231-7, 18922486.
42. Goossens L, Standaert B, Hartwig N, Hovels AM, Al MJ. Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions. Vaccine 2009, 27:2531-2532. 10.1016/j.vaccine.2009.02.036, 19428858.
43. Syriopoulou V, Kafetzis D, Theodoridou M, Syrogiannopoulos GA, Mantagos S, Trimis G, Mavrikou M, Konstantopoulos A. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta Paediatr 2011, 100:732-739. 10.1111/j.1651-2227.2010.02127.x, 21223372.
44. Marsella M, Raimondi L, Bergamini M, Sprocati M, Bigi E, De Sanctis V, Borgna-Pignatti C, Gabutti G. Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr 2009, 168:1423-1427. 10.1007/s00431-009-0942-z, 19255784.
45. Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis 1991, 164:277-283. 10.1093/infdis/164.2.277, 1649875.
46. Ward RL, Bernstein DI. Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. J Infect Dis 1994, 169:900-904. 10.1093/infdis/169.4.900, 8133107.
47. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996, 335:1022-1028. 10.1056/NEJM199610033351404, 8793926.
48. Pitzer VE, Atkins KE, Freiesleben de Blasio B, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar DU, Lopman BA. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One 2012, 7:e42320. 10.1371/journal.pone.0042320, 3418263, 22912699.